Store kursfald i USA får kæmpe dansk børsnotering til at vakle
- Words
- 27
- Chars
- 182
- AI summary
- Yes
Full story
Global financial market instability is threatening the plans to list Leo Pharma on the stock exchange in 2026. The pharmaceutical company will likely delay the listing until 2027. This change comes as a result of a significant drop in the US exchange rate.
Uro på de globale finansmarkeder truer nu planerne om at sende Leo Pharma på børsen i 2026. Ifølge Berlingskes oplysninger vil medicinalkæmpen formentlig udskyde noteringen til 2027.
Open article